Sector Investors News and Insights

ALVO

Alvotech and Dr. Reddy’s have partnered up to launch AVT03, a biosimilar of Prolia and Xgeva, in the United States, Europe, and the United Kingdom.

XLV Health Care / / ,

Alvotech, a biotech company that focuses on creating biosimilar drugs for patients around the world, has teamed up with Dr. Reddys Laboratories SA.

Alvotech and Dr. Reddy’s have partnered up to launch AVT03, a biosimilar of Prolia and Xgeva, in the United States, Europe, and the United Kingdom. Read More »

,

© 2025 ETF Sector

Scroll to Top

Subscribe to our Newsletter

Stay updated with the latests analysis and insights fromm etfsector.com

If you haven’t received your newsletter email, check your spam/junk folder and add us to your contacts to ensure delivery.